chr5-156954643-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_138379.3(TIMD4):āc.172C>Gā(p.Gln58Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000681 in 1,614,104 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_138379.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TIMD4 | NM_138379.3 | c.172C>G | p.Gln58Glu | missense_variant | 2/9 | ENST00000274532.7 | |
TIMD4 | NM_001146726.2 | c.172C>G | p.Gln58Glu | missense_variant | 2/8 | ||
TIMD4 | XM_017010021.2 | c.172C>G | p.Gln58Glu | missense_variant | 2/7 | ||
TIMD4 | XM_011534694.3 | c.172C>G | p.Gln58Glu | missense_variant | 2/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TIMD4 | ENST00000274532.7 | c.172C>G | p.Gln58Glu | missense_variant | 2/9 | 1 | NM_138379.3 | P2 | |
TIMD4 | ENST00000407087.4 | c.172C>G | p.Gln58Glu | missense_variant | 2/8 | 2 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152214Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251394Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135864
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461890Hom.: 0 Cov.: 33 AF XY: 0.00000688 AC XY: 5AN XY: 727248
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152214Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74368
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 02, 2023 | The c.172C>G (p.Q58E) alteration is located in exon 2 (coding exon 2) of the TIMD4 gene. This alteration results from a C to G substitution at nucleotide position 172, causing the glutamine (Q) at amino acid position 58 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at